Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Quinolones	O
/	O
Prednisone	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
F	O
with	O
PMH	O
of	O
dementia	B-Dementia
presenting	O
with	O
2	O
weeks	O
of	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
Per	O
report	O
from	O
nursing	B-Lives_in_carehome
home,	B-Lives_in_carehome
patient	O
has	O
had	O
personality	O
changes	O
for	O
___	O
weeks	O
and	O
has	O
been	O
more	O
withdrawn	O
than	O
baseline.	O
She	O
has	O
also	O
had	O
increasing	O
speech	O
difficulty	O
(mumbling	O
or	O
non-responsive)	O
and	O
mild	O
L	O
sided	O
facial	O
weakness.	O
She	O
is	O
oriented	B-Unspecified_cognitive_impairment
times	O
zero	O
at	O
baseline	O
and	O
has	O
been	O
for	O
a	O
long	O
time.	O
On	O
the	O
morning	O
of	O
presenation	O
the	O
patient	O
had	O
a	O
7	O
minute	O
episode	O
of	O
bilateral	O
uppper	O
extremity	O
trembling	O
where	O
patient	O
was	O
unresponsive.	O
She	O
was	O
given	O
0.5	O
mg	O
of	O
ativan	O
with	O
resolution	O
of	O
symptoms.	O
Nurse	O
there	O
is	O
unsure	O
if	O
patient	O
bit	O
her	O
tongue	O
or	O
became	O
incontinent	B-Urinary_incontinence
during	O
episode,	O
however	O
patient	O
is	O
incontinent	B-Faecal_incontinence
of	O
urien	B-Urinary_incontinence
and	O
stool	B-Faecal_incontinence
at	O
baseline.	O
No	O
record	O
of	O
seizure	B-Seizures
in	O
our	O
system	O
and	O
no	O
record	O
of	O
seizure	B-Seizures
from	O
___	O
___.	O
No	O
record	O
of	O
fever,	O
n/v/d	O
recently,	O
cough	O
or	O
SOB.	O
Pt	O
on	O
exam	O
here	O
noted	O
to	O
have	O
fixed	O
and	O
dilated	O
left	O
pupil	O
(per	O
___	O
this	O
is	O
patient's	O
baseline).	O
Moves	O
all	O
extremities	O
equally.	O
Unclear	O
if	O
facial	O
droop	O
as	O
pt	O
will	O
not	O
smile	O
on	O
command.	O
Witnessed	O
seizure	B-Seizures
today	O
-	O
pt	O
has	O
no	O
documented	O
h/o	O
seizure	B-Seizures
according	O
to	O
___.	O
Pt	O
recently	O
had	O
?stroke,	O
not	O
proven.	O
Patient	O
was	O
last	O
admitted	O
on	O
___	O
s/p	O
fall	B-Falls
with	O
hip	O
pain.	O
CT	O
head	B-Intracranial_haemorrhage
showed	O
no	O
acute	O
intracranial	B-Intracranial_haemorrhage
process	O
at	O
that	O
time.	O
Speaking	O
with	O
the	O
son,	O
he	O
reports	O
that	O
about	O
___	O
weeks	O
ago	O
he	O
noticed	O
the	O
patient	O
a	O
R	O
sided	O
facial	O
droop.	O
He	O
is	O
unsure	O
of	O
when	O
the	O
L	O
pupil	O
became	O
dilated.	O
He	O
also	O
reports	O
episodes	O
of	O
body	O
shaking	O
for	O
the	O
past	O
6	O
months	O
that	O
looked	O
like	O
seizure	B-Seizures
or	O
anxiety	O
to	O
him.	O
He	O
is	O
not	O
sure	O
if	O
todays	O
episode	O
was	O
similar	O
or	O
different.	O
In	O
the	O
ED,	O
initial	O
vital	O
signs	O
were	O
97.7	O
76	O
143/76	O
18	O
99%	O
4L	O
-	O
Nonverbal	O
since	O
arrival,	O
which	O
family	O
reports	O
is	O
her	O
recent	O
baseline.	O
-	O
Head	O
CT:	O
"Hypodensity	O
in	O
left	O
posterior	O
temporal-occiptial	O
region	O
concerning	O
for	O
acute	O
infarct,	O
new	O
from	O
___	O
-	O
UA:	O
positive	O
-	O
EKG:	O
SR	O
82	O
NA	O
NI	O
no	O
stemi	O
-	O
Given:	O
1gram	O
ceftriaxone,	O
no	O
IVF	O
-	O
___:	O
admit	O
to	O
geriatrics	O
under	O
___	O
-	O
son	O
changed	O
code	O
status	O
to	O
DNR/DNI	O
Most	O
Recent	O
Vitals:	O
86	O
141/88	O
20	O
97%	O
On	O
the	O
floor,	O
vitals	O
98.3,	O
140/68,	O
92,	O
24,	O
92%	O
2L	O
NC.	O
Patient	O
responds	O
verbal	O
stimuli	O
and	O
appears	O
to	O
track	O
with	O
eyes.	O
Review	O
of	O
sytems:	O
Per	O
son	O
and	O
rehab	O
center	O
(-)	O
nausea,	O
vomiting,	O
diarrhea,	O
cough,	O
fever,	O
dyspnea	O
Past	O
Medical	O
History:	O
alzheimer's	B-Dementia
dementia	B-Dementia
hypothyroidism	O
HTN	O
HLD	O
mixed	O
anxiety/depressive	O
disorder	O
urinary	B-Urinary_incontinence
incontinence	B-Urinary_incontinence
anemia	O
prior	O
hip	B-Hip_fracture
fracture	B-Hip_fracture
Social	O
History:	O
___	O
Family	O
History:	O
Nothing	O
per	O
husband.	O
Physical	O
Exam:	O
Admission:	O
Vitals-	O
98.3,	O
140/68,	O
92,	O
24,	O
92%	O
2L	O
NC	O
General-	O
Alert,	O
oriented	B-Unspecified_cognitive_impairment
x0,	B-Unspecified_cognitive_impairment
no	O
acute	O
distress	O
HEENT-	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear	O
Neck-	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs-	O
Clear	O
to	O
auscultation	O
bilaterally	O
frontal	O
lung	O
fields	O
CV-	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Abdomen-	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
GU-	O
no	O
foley	O
Ext-	O
warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Neuro-moving	O
all	O
extremities,	O
does	O
not	O
follow	O
commands,	O
L	O
pupil	O
fixed	O
and	O
dilated	O
Discharge:	O
Vitals-	O
97.4,	O
104-150/69-75,	O
88,	O
18,	O
97	O
2LNC	O
General-	O
Arrousable,	O
oriented	B-Unspecified_cognitive_impairment
x0,	B-Unspecified_cognitive_impairment
no	O
acute	O
distress	O
HEENT-	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear,	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs-	O
Upper	O
airway	O
noises,	O
mild	O
wheezing,	O
poor	O
inspiratory	O
effort,	O
no	O
accessory	O
muscle	O
use	O
CV-	O
RRR,	O
normal	O
S1	O
+	O
S2,	O
no	O
MRG	O
Abdomen-	O
soft,	O
NT,	O
ND,	O
+BS,	O
no	O
rebound	O
tenderness	O
or	O
guarding	O
GU-	O
no	O
foley	O
Ext-	O
WWP,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Neuro-moving	O
all	O
extremities,	O
does	O
not	O
follow	O
commands,	O
L	O
pupil	O
fixed	O
and	O
dilated	O
Pertinent	O
Results:	O
Admission:	O
___	O
11:27AM	O
WBC-16.0*#	O
RBC-3.64*#	O
HGB-11.1*	O
HCT-34.0*	O
MCV-93	O
MCH-30.5	O
MCHC-32.7	O
RDW-12.9	O
___	O
11:27AM	O
NEUTS-84.2*	O
LYMPHS-12.0*	O
MONOS-2.4	O
EOS-1.1	O
BASOS-0.3	O
___	O
11:27AM	O
PLT	O
COUNT-332#	O
___	O
11:27AM	O
___	O
PTT-28.1	O
___	O
___	O
11:27AM	O
TSH-0.23*	O
___	O
11:27AM	O
ALBUMIN-3.5	O
___	O
11:27AM	O
LIPASE-23	O
___	O
11:27AM	O
ALT(SGPT)-16	O
AST(SGOT)-21	O
CK(CPK)-64	O
ALK	O
PHOS-102	O
TOT	O
BILI-0.2	O
___	O
11:27AM	O
estGFR-Using	O
this	O
___	O
11:27AM	O
GLUCOSE-109*	O
UREA	O
N-25*	O
CREAT-1.4*	O
SODIUM-147*	O
POTASSIUM-4.0	O
CHLORIDE-107	O
TOTAL	O
CO2-28	O
ANION	O
GAP-16	O
___	O
11:39AM	O
LACTATE-1.3	O
___	O
11:39AM	O
___	O
COMMENTS-GREEN	O
TOP	O
___	O
11:45AM	O
URINE	O
MUCOUS-RARE	O
___	O
11:45AM	O
URINE	O
AMORPH-RARE	O
___	O
11:45AM	O
URINE	O
RBC-3*	O
WBC-96*	O
BACTERIA-FEW	O
YEAST-NONE	O
EPI-<1	O
___	O
11:45AM	O
URINE	O
BLOOD-NEG	O
NITRITE-POS	O
PROTEIN-TR	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-6.5	O
LEUK-LG	O
___	O
11:45AM	O
URINE	O
COLOR-Straw	O
APPEAR-Hazy	O
SP	O
___	O
Interim:	O
___	O
07:30AM	O
BLOOD	O
WBC-11.1*	O
RBC-3.07*	O
Hgb-9.5*	O
Hct-28.1*	O
MCV-92	O
MCH-31.0	O
MCHC-33.9	O
RDW-12.3	O
Plt	O
___	O
Micro:	O
___	O
11:40	O
am	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
11:45	O
am	O
URINE	O
Site:	O
CATHETER	O
CATHETER.	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
PSEUDOMONAS	O
AERUGINOSA.	O
>100,000	O
ORGANISMS/ML..	O
sensitivity	O
testing	O
performed	O
by	O
Microscan.	O
CEFEPIME	O
<=2	O
MCG/ML.	O
MEROPENEM	O
<=1	O
MCG/ML.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
PSEUDOMONAS	O
AERUGINOSA	O
|	O
CEFEPIME--------------	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CIPROFLOXACIN---------	O
<=0.5	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------	O
S	O
PIPERACILLIN/TAZO-----	O
<=8	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
___	O
EKG:	O
NSR	O
no	O
ST	O
changes	O
Imaging:	O
CT	B-Intracranial_haemorrhage
HEAD	B-Intracranial_haemorrhage
W/O	O
CONTRAST	O
Study	O
Date	O
of	O
___	O
There	O
is	O
a	O
new	O
area	O
of	O
hypodensity	O
in	O
the	O
left	O
posterior	O
temporal	O
region	O
compared	O
to	O
the	O
CT	O
from	O
___,	O
with	O
sulcal	O
effacement,	O
cytotoxic	O
edema,	O
and	O
loss	O
of	O
grey-white	O
matter	O
differentiation,	O
findings	O
compatible	O
with	O
acute	O
to	O
subacute	O
watershed	O
infarct.	O
There	O
is	O
no	O
evidence	O
of	O
hemorrhage	B-Intracranial_haemorrhage
or	O
shift	O
of	O
normally	O
midline	O
structures.	O
Prominent	O
ventricles	O
and	O
sulci	O
suggests	O
age-related	O
atrophy.	O
Periventricular	O
white	O
matter	O
hypodensities	O
are	O
consistent	O
with	O
chronic	O
small	O
vessel	O
ischemic	O
disease.	O
The	O
basal	O
cisterns	O
appear	O
patent.	O
No	O
fracture	O
is	O
identified.	O
The	O
visualized	O
paranasal	O
sinuses,	O
mastoid	O
air	O
cells	O
and	O
middle	O
ear	O
cavities	O
are	O
clear.	O
The	O
globes	O
are	O
unremarkable.	O
IMPRESSION:	O
Findings	O
compatible	O
with	O
an	O
acute	O
to	O
subacute	O
watershed	O
infarct	O
within	O
the	O
left	O
posterior	O
temporal	O
region.	O
CHEST	O
(SINGLE	O
VIEW)	O
Study	O
Date	O
of	O
___	O
IMPRESSION:	O
Bibasilar	O
opacities	O
may	O
reflect	O
atelectasis	O
but	O
infection	O
is	O
not	O
completely	O
excluded.	O
Mild	O
pulmonary	O
vascular	O
congestion,	O
slightly	O
improved	O
from	O
the	O
prior	O
study.	O
CHEST	O
(PORTABLE	O
AP)	O
Study	O
Date	O
of	O
___	O
FINDINGS:	O
As	O
compared	O
to	O
the	O
previous	O
radiograph,	O
the	O
patient	O
has	O
developed	O
a	O
left	O
pleural	O
effusion	O
and	O
an	O
area	O
of	O
newly	O
appeared	O
left	O
parenchymal	O
consolidation	O
in	O
the	O
retrocardiac	O
and	O
left	O
basal	O
lung	O
areas.	O
In	O
the	O
appropriate	O
clinical	O
setting,	O
pneumonia	B-Lower_respiratory_tract_infection
with	O
an	O
associated	O
pleural	O
effusion	O
might	O
be	O
the	O
most	O
likely	O
differential	O
diagnosis.	O
At	O
the	O
time	O
of	O
dictation	O
and	O
observation,	O
the	O
referring	O
physician,	O
___,	O
was	O
paged	O
for	O
notification.	O
Normal	O
size	O
of	O
the	O
cardiac	O
silhouette.	O
Normal-appearing	O
right	O
lung.	O
CHEST	O
(PORTABLE	O
AP)	O
Study	O
Date	O
of	O
___	O
FINDINGS:	O
As	O
compared	O
to	O
the	O
previous	O
radiograph,	O
the	O
severity	O
and	O
extent	O
of	O
the	O
pre-existing	O
left	O
lower	O
lung	O
opacity	O
has	O
minimally	O
decreased.	O
However,	O
the	O
opacity	O
is	O
overall	O
still	O
massive.	O
The	O
size	O
of	O
the	O
cardiac	O
silhouette	O
is	O
constant.	O
The	O
right	O
lung	O
is	O
unchanged	O
and	O
normal.	O
Pending	O
studies:	O
___	O
Neurophysiology	O
EEG	O
Pending	O
___	O
Neurophysiology	O
EEG	O
Pending	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
F	O
with	O
PMH	O
Alzheimer's	B-Dementia
dementia	B-Dementia
presenting	O
with	O
cc	O
of	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
found	B-Delirium
to	O
have	O
a	O
recent	O
stroke,	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection,	B-Urinary_tract_infection
and	O
seizures.	B-Seizures
Hospital	O
course	O
was	O
complicated	O
by	O
HCAP,	B-Urinary_tract_infection
delirium,	B-Delirium
and	O
recurrent	O
aspirations.	O
#	O
Altered	B-Delirium
mental	B-Delirium
status:	B-Delirium
Patient	O
presented	O
with	O
2	O
week	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status	B-Delirium
including	O
personality	O
changes	O
with	O
more	O
withdrawn	O
appearance	O
upon	O
baseline	O
advanced	O
dementia,	B-Dementia
increased	O
speech	O
difficulties,	O
and	O
mild	O
facial	O
weakness	O
of	O
R	O
side.	O
She	O
also	O
had	O
an	O
episode	O
of	O
possible	O
seizure	B-Seizures
that	O
was	O
treated	O
with	O
0.5mg	O
ativan.	O
A	O
CT	O
showed	O
evidence	O
of	O
a	O
subacute	O
stroke	O
that	O
is	O
new	O
from	O
___.	O
She	O
also	O
had	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
Medication	O
side	O
effect	O
from	O
lorazepam	O
also	O
may	O
have	O
been	O
contributing,	O
as	O
elderly	O
patients	O
are	O
very	O
sensitive	O
to	O
benzodiazepines.	O
Seizure	B-Seizures
may	O
also	O
be	O
contributing	O
to	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
#	O
Stroke:	O
Patient	O
presented	O
with	O
2	O
week	O
history	O
of	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
and	O
R	O
facial	O
assymetry.	O
On	O
exam	O
she	O
was	O
also	O
noted	O
to	O
have	O
a	O
fixed	O
and	O
dilated	O
Left	O
pupil.	O
CT	O
showed	O
a	O
hypodensity	O
in	O
left	O
posterior	O
temporal-occiptial	O
region	O
concerning	O
for	O
acute	O
infarct,	O
new	O
from	O
___.	O
Patient	O
seen	O
and	O
evaluated	O
by	O
neurology	O
who	O
felt	O
this	O
was	O
a	O
subacute	O
stroke,	O
likely	O
dating	O
back	O
to	O
onset	O
of	O
R	O
facial	O
droop	O
about	O
___	O
weeks	O
ago.	O
Patient	O
continued	O
on	O
aspirin	O
81	O
mg	O
until	O
difficulty	O
swallowing	O
and	O
switched	O
to	O
150	O
mg	O
PR.	O
#	O
Urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection:	B-Urinary_tract_infection
Leukocytosis	O
and	O
positive	O
UA	O
on	O
admission	O
with	O
lactate	O
of	O
1.3	O
and	O
no	O
fevers.	O
Urine	O
culture	O
done	O
at	O
___	O
showed	O
Proteus	O
Mirabilis	O
sensitive	O
to	O
ceftriaxone.	O
Patient	O
treated	O
with	O
4	O
days	O
of	O
ceftriaxone	O
in	O
house	O
and	O
switched	O
to	O
cefepime	O
for	O
dual	O
treatment	O
of	O
HCAP	B-Lower_respiratory_tract_infection
and	O
urine	O
culture	O
growing	O
Pseudomonas	O
aeruginosa.	O
#	O
Seizure:	B-Seizures
Patient	O
presented	O
from	O
skilled	O
nursing	O
facility	O
with	O
episode	O
concerning	O
for	O
seizure,	B-Seizures
with	O
limb	O
shaking/trembling	O
and	O
decreased	O
level	O
of	O
responsivenes.	O
Patient	O
is	O
incontinent	B-Urinary_incontinence
at	O
baseline.	O
Son	O
reported	O
that	O
patient	O
has	O
been	O
having	O
seizure	B-Seizures
like	O
episodes	O
for	O
about	O
6	O
months.	O
She	O
has	O
no	O
history	O
of	O
seizure.	B-Seizures
CK	O
was	O
normal	O
at	O
63.	O
She	O
had	O
a	O
20	O
minute	O
EEG	O
showing	O
encephalopathy	B-Delirium
with	O
multiple	O
spikes,	O
without	O
evidence	O
of	O
seizure.	B-Seizures
Per	O
neurology	O
recommendations,	O
the	O
patient	O
was	O
started	O
on	O
Keppra	O
500mg	O
BID.	O
She	O
also	O
had	O
a	O
24	O
hour	O
EEG	O
which	O
showed	O
similar	O
findings	O
to	O
20	O
minute	O
EEG.	O
Upon	O
discharge	O
she	O
will	O
have	O
an	O
outpatient	O
extended	O
EEG	O
after	O
one	O
week	O
of	O
treatment	O
and	O
follow	O
up	O
with	O
neurology.	O
#	O
Pneumonia:	B-Lower_respiratory_tract_infection
Patient	O
presented	O
with	O
new	O
oxygen	O
requirement.	O
CXR	O
noted	O
bibasilar	O
opacities	O
which	O
may	O
reflect	O
atelectasis	O
but	O
infection	B-Lower_respiratory_tract_infection
is	O
not	O
completely	O
excluded.	O
A	O
repeat	O
CXR	O
on	O
___	O
showed	O
a	O
left	O
pleural	O
effusion	O
and	O
an	O
area	O
of	O
newly	O
appeared	O
left	O
parenchymal	O
consolidation	O
in	O
the	O
retrocardiac	O
and	O
left	O
basal	O
lung	O
areas.	O
The	O
patient	O
was	O
started	O
on	O
vancomycin	O
and	O
cefepime	O
for	O
hospital	B-Lower_respiratory_tract_infection
acquired	B-Lower_respiratory_tract_infection
pneumonia.	B-Lower_respiratory_tract_infection
She	O
received	O
a	O
PICC	O
line	O
for	O
continued	O
antibiotic	O
therapy.	O
#	O
Hypernatremia:	O
Sodium	O
elevated	O
to	O
147	O
on	O
admission	O
(previous	O
admission	O
ranged	O
from	O
141-144).	O
Given	O
baseline	O
dementia	B-Dementia
and	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
this	O
may	O
be	O
due	O
to	O
patient	O
not	O
being	O
able	O
to	O
get	O
water.	O
Patient	O
became	O
unable	O
to	O
in	O
PO	O
hydration	O
and	O
was	O
given	O
about	O
1	O
Liter	O
of	O
D5W	O
for	O
hypernatremia	O
on	O
most	O
days.	O
#	O
Goals	O
of	O
Care:	O
Patient	O
admitted	O
with	O
poor	O
functional	O
baseline.	O
She	O
deteriorated	O
during	O
this	O
admission	O
in	O
the	O
setting	O
of	O
a	O
recent	O
stroke,	O
possible	O
seizure	B-Seizures
activity,	O
pneumonia	B-Lower_respiratory_tract_infection
and	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
The	O
patient	O
was	O
unable	O
to	O
take	O
in	O
oral	O
medications	O
or	O
food	O
and	O
was	O
supplemented	O
with	O
D5W.	O
A	O
speech	O
and	O
swallow	O
evaluation	O
was	O
done	O
and	O
the	O
patient	O
was	O
unable	O
to	O
safely	O
take	O
in	O
anything	O
by	O
mouth.	O
She	O
may	O
improve	O
with	O
treatment	O
of	O
pneumonia	B-Lower_respiratory_tract_infection
and	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
and	O
should	O
be	O
reevaluated	O
at	O
that	O
time.	O
If	O
her	O
functional	O
status	O
continues	O
to	O
be	O
depressed,	O
particularly	O
with	O
swallowing,	O
a	O
goals	O
of	O
care	O
discussion	O
will	O
be	O
needed	O
by	O
the	O
team	O
of	O
providers	O
at	O
___	O
___	O
who	O
know	O
the	O
patient	O
best.	O
#	O
C	O
difficile:	O
A	O
clostridium	O
difficile	O
toxin	O
was	O
checked	O
due	O
to	O
high	O
white	O
blood	O
cell	O
count.	O
The	O
patient	O
was	O
not	O
symptomatic	O
from	O
this	O
and	O
was	O
having	O
___	O
bowel	O
movements	O
per	O
day.	O
Because	O
of	O
her	O
poor	O
baseline	O
functioning,	O
she	O
was	O
started	O
on	O
IV	O
flagyl	O
and	O
will	O
need	O
to	O
complete	O
a	O
10	O
day	O
course	O
of	O
antibiotics.	O
#	O
Chronic	O
renal	O
failure:	O
Cr	O
on	O
admission	O
1.4.	O
Baseline	O
per	O
___	O
records	O
is	O
1.5-1.7.	O
Medications	O
were	O
renally	O
dosed.	O
#	O
Dementia:	B-Dementia
Patient	O
has	O
baseline	O
dementia	B-Dementia
and	O
is	O
oriented	B-Delirium
times	O
zero.	O
She	O
was	O
placed	O
on	O
___	O
protocol.	O
Conditions	O
that	O
may	O
exacerbate	O
dementia	B-Dementia
were	O
treated	O
as	O
described.	O
#	O
HTN:	O
Patient	O
continued	O
on	O
home	O
metoprolol	O
tartrate	O
25	O
mg	O
daily.	O
#	O
Hypothyroidism:	O
Patient	O
continued	O
on	O
levothyroxine	O
100	O
mcg	O
daily.	O
TSH	O
low	O
at	O
0.23,	O
Free	O
T4	O
6.6	O
and	O
Free	O
T3	O
64.	O
She	O
was	O
switched	O
to	O
50	O
mcg	O
of	O
IV	O
levothyroxine	O
due	O
to	O
inability	O
to	O
swallow	O
pills.	O
Transitional	O
Issues:	O
-	O
Goals	O
of	O
care	O
as	O
described	O
above	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Cefpodoxime	O
Proxetil	O
100	O
mg	O
PO	O
Q24H	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Mirtazapine	O
30	O
mg	O
PO	O
HS	O
4.	O
Lorazepam	O
0.5	O
mg	O
PO	O
Q6H:PRN	O
agitation	O
5.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
6.	O
Citalopram	O
20	O
mg	O
PO	O
DAILY	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
9.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Citalopram	O
20	O
mg	O
PO	O
DAILY	O
2.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
3.	O
Mirtazapine	O
30	O
mg	O
PO	O
HS	O
4.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
5.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
30	O
mg	O
PO	O
DAILY	O
RX	O
*lansoprazole	O
[Prevacid	O
SoluTab]	O
30	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
6.	O
CefePIME	O
2	O
g	O
IV	O
Q24H	O
last	O
day	O
___	O
7.	O
Vancomycin	O
1000	O
mg	O
IV	O
Q48H	O
Last	O
day	O
___	O
8.	O
Heparin	O
Flush	O
(10	O
units/ml)	O
2	O
mL	O
IV	O
PRN	O
line	O
flush	O
9.	O
LeVETiracetam	O
500	O
mg	O
IV	O
Q12H	O
10.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
IV	O
DAILY	O
11.	O
MetRONIDAZOLE	O
(FLagyl)	O
500	O
mg	O
IV	O
Q8H	O
Last	O
day	O
___	O
12.	O
Aspirin	O
___AILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
subacute	O
stroke,	O
hospital	B-Lower_respiratory_tract_infection
acquired	B-Lower_respiratory_tract_infection
pneumonia,	B-Lower_respiratory_tract_infection
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection,	B-Urinary_tract_infection
hypernatremia,	O
seizure	B-Seizures
Secondary:	O
Dementia,	B-Dementia
hypertension	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Dementia
-	O
always.	O
Level	O
of	O
Consciousness:	O
Lethargic	O
but	O
arousable.	O
Activity	O
Status:	O
Out	O
of	O
Bed	O
with	O
assistance	B-Mobile_with_assistance
to	O
chair	B-Bed_Chairbound
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___	O
___.	O
You	O
were	O
admitted	O
with	O
a	O
change	B-Delirium
in	O
your	O
mental	B-Delirium
status.	B-Delirium
You	O
were	O
treated	O
with	O
antibiotics	O
for	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
You	O
also	O
had	O
a	O
question	O
of	O
a	O
seizure	B-Seizures
and	O
had	O
an	O
EEG	O
to	O
look	O
for	O
evidence	O
of	O
seizure	B-Seizures
and	O
were	O
started	O
on	O
Keppra	O
to	O
prevent	O
seizures.	B-Seizures
You	O
will	O
need	O
to	O
follow	O
up	O
with	O
neurology	O
for	O
an	O
EEG	O
and	O
a	O
follow	O
up	O
appointment	O
as	O
scheduled	O
below.	O
About	O
___	O
weeks	O
prior	O
to	O
coming	O
in,	O
the	O
right	O
side	O
of	O
your	O
face	O
became	O
weak	O
and	O
your	O
mental	B-Delirium
status	B-Delirium
changed.	B-Delirium
A	O
CT	O
scan	O
of	O
your	O
head	O
showed	O
a	O
stroke	O
that	O
likely	O
occured	O
at	O
that	O
time.	O
You	O
also	O
developed	O
a	O
pneumonia	B-Lower_respiratory_tract_infection
that	O
was	O
seen	O
on	O
chest	O
x-ray.	O
You	O
were	O
treated	O
with	O
IV	O
antibiotics	O
and	O
will	O
continue	O
these	O
at	O
___.	O
In	O
addition,	O
your	O
mental	B-Delirium
status	B-Delirium
fluctuated	B-Delirium
during	O
your	O
stay.	O
This	O
made	O
your	O
swallowing	O
worse,	O
and	O
you	O
can	O
not	O
currently	O
take	O
anything	O
by	O
mouth.	O
Medication	O
changes:	O
Please	O
start	O
Keppra	O
500	O
mg	O
twice	O
a	O
day	O
Please	O
start	O
CefePIME	O
2	O
g	O
IV	O
Q24H	O
last	O
day	O
___	O
Please	O
start	O
Vancomycin	O
1000	O
mg	O
IV	O
Q48H	O
Last	O
day	O
___	O
Please	O
start	O
Flagyl	O
500	O
mg	O
every	O
8	O
hours	O
for	O
ten	O
days	O
Last	O
day	O
___	O
Please	O
change	O
levothyroxine	O
from	O
100micrograms	O
PO	O
to	O
50	O
micrograms	O
IV	O
daily	O
Please	O
stop	O
taking	O
Lorazepam	O
Please	O
hold	O
oral	O
medications	O
until	O
patient	O
able	O
to	O
take	O
PO	O
Followup	O
Instructions:	O
___	O

